Mandate

Vinge advises EQT X in connection with its investment in HVD Group and Next One Technology

Vinges advises the EQT X fund (or “EQT Private Equity”) in connection with its investment in the Nordic software companies HVD Group (Hantverksdata) and Next (Next One Technology). Both companies serve the tradespeople and construction industry, with HVD Group focused on installation and service professions – such as electricians, plumbers, heating and ventilation firms – while Next is focused on contractors. HVD Group’s platform complements that of Next, and the investment thus paves the way for a further strengthened product offering, which builds on both companies’ strong customer satisfaction scores.

EQT Private Equity will invest in HVD Group and Next together with the existing HVD Group shareholder Adelis, who will increase its investment in the new combined company.

Both transactions are expected to close in February 2024.

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Elsie Nassar, Amanda Steen, Maximilian Bengtsson and Jonatan Stentorp (M&A), Louise Brorsson Salomon and Jolinn Uhlin (Financing), Marcus Glader, Daniel Wendelsson, Sebastian Örndahl, David Olander and Adam Löfquist (Regulatory), Axel Lennartsson (IPR), Mathilda Persson, Jolene Reimerson, Lisa Hörnqvist and Mario Saad (IT / GDPR), Christoffer Nordin, Carl Lexenberg and Arthur Kinski (Agreements), Emil Lindwall and Victor Björkheim (Employment) and Emelie Schoning (Transaction Support Coordinator).

Read the client's press release

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025